139 related articles for article (PubMed ID: 32156628)
1. Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts.
Pu J; Gao T; Zheng R; Fang Y; Ruan Y; Jin C; Shen T; Tian J; Zhang B
Brain Res Bull; 2020 Jun; 159():9-15. PubMed ID: 32156628
[TBL] [Abstract][Full Text] [Related]
2. Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons.
Ren Y; Jiang H; Hu Z; Fan K; Wang J; Janoschka S; Wang X; Ge S; Feng J
Stem Cells; 2015 Jan; 33(1):68-78. PubMed ID: 25332110
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
[TBL] [Abstract][Full Text] [Related]
4. Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell-Derived A9 Dopaminergic Neurons.
Pu J; Lin L; Jiang H; Hu Z; Li H; Yan Z; Zhang B; Feng J
Mov Disord; 2023 Jul; 38(7):1273-1281. PubMed ID: 37166002
[TBL] [Abstract][Full Text] [Related]
5. Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons.
Schwartzentruber A; Boschian C; Lopes FM; Myszczynska MA; New EJ; Beyrath J; Smeitink J; Ferraiuolo L; Mortiboys H
Sci Rep; 2020 Sep; 10(1):15485. PubMed ID: 32968089
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin E3 ligase Parkin regulates neuronal Ca
Grimaldo L; Sandoval A; Duran P; Gómez Flores-Ramos L; Felix R
J Neurophysiol; 2022 Dec; 128(6):1555-1564. PubMed ID: 36350063
[TBL] [Abstract][Full Text] [Related]
8. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells.
Jiang H; Ren Y; Yuen EY; Zhong P; Ghaedi M; Hu Z; Azabdaftari G; Nakaso K; Yan Z; Feng J
Nat Commun; 2012 Feb; 3():668. PubMed ID: 22314364
[TBL] [Abstract][Full Text] [Related]
9. Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: Impact on α-synuclein protein levels.
González-Barbosa E; García-Aguilar R; Vega L; Cabañas-Cortés MA; Gonzalez FJ; Segovia J; Morales-Lázaro SL; Cisneros B; Elizondo G
Biochem Pharmacol; 2019 Oct; 168():429-437. PubMed ID: 31404530
[TBL] [Abstract][Full Text] [Related]
10. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
Jiang H; Ren Y; Zhao J; Feng J
Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
Pickrell AM; Huang CH; Kennedy SR; Ordureau A; Sideris DP; Hoekstra JG; Harper JW; Youle RJ
Neuron; 2015 Jul; 87(2):371-81. PubMed ID: 26182419
[TBL] [Abstract][Full Text] [Related]
12. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
13. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice.
Noda S; Sato S; Fukuda T; Tada N; Uchiyama Y; Tanaka K; Hattori N
Neurobiol Dis; 2020 Mar; 136():104717. PubMed ID: 31846738
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons.
Yokota M; Kakuta S; Shiga T; Ishikawa KI; Okano H; Hattori N; Akamatsu W; Koike M
Mol Brain; 2021 Mar; 14(1):58. PubMed ID: 33757554
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations.
van der Merwe C; Loos B; Swart C; Kinnear C; Henning F; van der Merwe L; Pillay K; Muller N; Zaharie D; Engelbrecht L; Carr J; Bardien S
Biochem Biophys Res Commun; 2014 May; 447(2):334-40. PubMed ID: 24721425
[TBL] [Abstract][Full Text] [Related]
16. Role of Nurr1 in the Generation and Differentiation of Dopaminergic Neurons from Stem Cells.
Rodríguez-Traver E; Solís O; Díaz-Guerra E; Ortiz Ó; Vergaño-Vera E; Méndez-Gómez HR; García-Sanz P; Moratalla R; Vicario-Abejón C
Neurotox Res; 2016 Jul; 30(1):14-31. PubMed ID: 26678495
[TBL] [Abstract][Full Text] [Related]
17. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
18. The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.
Benskey MJ; Manfredsson FP; Lookingland KJ; Goudreau JL
Neurotoxicology; 2015 Jan; 46():1-11. PubMed ID: 25447324
[TBL] [Abstract][Full Text] [Related]
19. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
20. Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y).
Tariq M; Liu H; Ibañez DP; Li Y; Chen S; Jiang M; Fan W; Zhao P; Luo Z; Wang D; Kanwal S
Stem Cell Res; 2020 May; 45():101822. PubMed ID: 32387897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
